Clinical Trials Browser

Phase 2 × Esophagitis × Clear all

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms, Esophagitis

NCT06958445 2025-05-06

SAFE

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

NCT06392971 2024-05-01

Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms, Esophagitis, Radiation Injuries

NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Phase 2 Terminated

39 enrolled 12 charts

Esophagitis

NCT02577393 2020-04-28

Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy

Phase 2 Unknown

Esophagitis, Lung Neoplasms

NCT01262560 2017-08-31

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Phase 2 Completed

163 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Deglutition Disorders, Esophagitis, Lung Neoplasms, Pain, Small Cell Lung Carcinoma

NCT00081315 2007-08-21

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Esophagitis, Pneumonia